Fate Therapeutics Inc. buy melinda
Start price
11.05.17
/
50%
€3.63
Target price
30.10.17
€4.15
Performance (%)
14.68%
End price
30.10.17
€4.16
Summary
This prediction ended on 30.10.17 with a price of €4.16. The prediction had a final performance of 14.68%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Fate Therapeutics Inc. | 6.597% | 6.597% | -33.829% | -94.644% |
iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by melinda for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
hat $
(Zielkurs erreicht)
Stopped prediction by melinda for Fate Therapeutics Inc.
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€32.80
02.10.20
02.10.20
€38.00
04.11.21
04.11.21
54.39%
05.11.21
05.11.21
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€16.88
17.03.19
17.03.19
€18.04
22.04.19
22.04.19
-15.13%
22.04.19
22.04.19